Does DANTROLENE Cause Neuroleptic malignant syndrome? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Neuroleptic malignant syndrome have been filed in association with DANTROLENE (Dantrolene Sodium). This represents 16.8% of all adverse event reports for DANTROLENE.
50
Reports of Neuroleptic malignant syndrome with DANTROLENE
16.8%
of all DANTROLENE reports
12
Deaths
41
Hospitalizations
How Dangerous Is Neuroleptic malignant syndrome From DANTROLENE?
Of the 50 reports, 12 (24.0%) resulted in death, 41 (82.0%) required hospitalization, and 15 (30.0%) were considered life-threatening.
Is Neuroleptic malignant syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DANTROLENE. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does DANTROLENE Cause?
Drug ineffective (74)
Off label use (30)
Respiratory failure (20)
Drug ineffective for unapproved indication (18)
Nausea (17)
Dizziness (15)
Pyrexia (15)
Asthenia (14)
Decreased appetite (14)
Product use issue (14)
What Other Drugs Cause Neuroleptic malignant syndrome?
QUETIAPINE (1,756)
OLANZAPINE (1,748)
RISPERIDONE (1,258)
HALOPERIDOL (1,244)
ARIPIPRAZOLE (1,138)
CLOZAPINE (899)
LITHIUM (506)
LORAZEPAM (437)
PALIPERIDONE (355)
VALPROIC ACID (352)
Which DANTROLENE Alternatives Have Lower Neuroleptic malignant syndrome Risk?
DANTROLENE vs DAPAGLIFLOZIN
DANTROLENE vs DAPAGLIFLOZIN PROPANEDIOL
DANTROLENE vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DANTROLENE vs DAPRODUSTAT
DANTROLENE vs DAPSONE